Blood Ketone Meter Market, by Product Type (Only Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, and Consumables), by Application (Human and Veterinary), by End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Home Care Settings, Veterinary Hospitals and Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : May 2023

Code : CMI3498

Pages :170

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Leading Companies

Global Blood Ketone Meter Market – Key Players

Major players operating in the blood ketone meter market include Abbott Laboratories, ACON Laboratories Inc., Keto-Mojo, EKF Diagnostics, Taidoc Technology Corporation, Apex Biotechnology Corporation, Bruno MD, Nova Biomedical, Nipro Corporation, ForaCare Inc., GlucoRx Limited, and PortaCheck Inc.

Global Blood Ketone Meter Market: Key Developments

For instance, in February 2023, Assure Tech, a high-tech biotechnology company specializing in research and development, production, and sale of diagnostic reagents, point-of-care testing, and biological materials launched a new platform for comprehensive health solutions for pets in China. This platform includes a glucose and blood ketone monitoring device that offers a novel technique for diagnosing blood ketone and glucose levels in pets.

In August 2021, Fitbit and LifeScan, a world leader in blood glucose monitoring serving more than 20 million people with diabetes, have teamed up to provide people with diabetes with a more thorough understanding of how lifestyle factors can affect the blood glucose levels. Life style factors like regular activity, diet, and sleep can affect blood glucose levels, as well as tools that can help lead to healthy lifestyle changes.

For instance, in February 14 2023, Insulet Corporation, is an innovative medical device company, announced it had acquired the assets of Automated Glucose Control LLC (AGC), a company in Palo Alto, California focused on developing and commercializing best in class automated insulin delivery technology.